Successful oral desensitization with crizotinib after crizotinib-induced hepatitis in an anaplastic lymphoma kinase-rearranged non-small-cell lung cancer patient: A case report.

导出 LinkOut

翻译打印收藏纠错

作者： Yuto,Yasuda ^[1] ; Yasuyo,Nishikawa ^[2] ; Yuichi,Sakamori ^[1] ; Makoto,Terao ^[3] ; Kentaro,Hashimoto ^[4] ; Tomoko,Funazo ^[1] ; Takashi,Nomizo ^[1] ; Takahiro,Tsuji ^[1] ; Hironori,Yoshida ^[1] ; Hiroki,Nagai ^[1] ; Hiroaki,Ozasa ^[1] ; Toyohiro,Hirai ^[1] ; Young Hak,Kim ^[1]

作者单位： Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan. ^[1] Department of Surgery, Gastrointestinal Center, Kyoto-Katsura Hospital, Kyoto 615-8256, Japan. ^[2] Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto 606-8507, Japan. ^[3] Department of Respiratory Medicine, Shiga Medical Center for Adults, Moriyama, Shiga 524-0022, Japan. ^[4]

关键词 anaplastic lymphoma kinase crizotinib desensitization hepatitis non-small-cell lung cancer

DOI 10.3892/mco.2017.1310

PMID 28781805

发布时间 2020-10-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览40

Molecular and clinical oncology

2017年7卷2期

295-297页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Successful oral desensitization with crizotinib after crizotinib-induced hepatitis in an anaplastic lymphoma kinase-rearranged non-small-cell lung cancer patient: A case report.

Molecular and clinical oncology

相似文献

Molecular and clinical oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Successful oral desensitization with crizotinib after crizotinib-induced hepatitis in an anaplastic lymphoma kinase-rearranged non-small-cell lung cancer patient: A case report.

Molecular and clinical oncology

相似文献

Molecular and clinical oncology

相关期刊

检索历史清除